Skip to content
Logo text: ISPOR Improving healthcare decisions

Health Technology Assessment Central

The HTA Resource Center for Informing Healthcare Decisions

  • Home
  • What Is HTA?
  • HTA News and Events
  • Resource Library
  • Governance
  • Policy Interchange
  • Training and Development
« Back to ISPOR.org

News

CVS sets a cost-effectiveness threshold for health plan coverage of most new drugs

August 24, 2018

https://www.statnews.com/pharmalot/2018/08/14/cvs-cost-effectiveness-new-drugs/

Posted in: Uncategorized

Post navigation

← Irish HTA Official Calls for All New Patients to Start With Biosimilars
Professor says HSE should ‘take seriously’ cheaper medicines →

News

The new definition of HTA: A milestone in international collaboration
Impact of a Global Pandemic on Health Technology Assessment
NEW HTAi – ISPOR Joint Deliberative Processes for HTA Task Force
Strategic collaboration announced by NICE and Health Technology Wales
NICE and LSE announce new Executive MSc in Evaluation of Health Care Interventions and Outcomes degree program, starting in April 2020
Why HTA and Pooled Purchasing Must Be at the Heart of Global Health Transitions
Health Technology Assessment Around the World: Broadening the Understanding of Cross-Country Differences
Ghana’s HTA agenda and UHC, what difference could HTA make?
AMCP releases the AMCP Format for Formulary Submissions, version 4.1
The ‘Top 10’ Challenges for Health Technology Assessment: INAHTA Viewpoint

Twitter

Tweets about #HTA

#HTA

UweSiebert9Uwe Siebert@UweSiebert9·
11h

We extended our int’l. #HTADS Continuing Education Program covering #DataScience, #DecisionScience & #HTA. Courses on Clinical Epidemiology, Statistics, Decision Modeling, #CausalInference, HTA & more. All with hands-on exercises/computer programming. See http://htads.org.

Reply on Twitter 1307624084256288769Retweet on Twitter 13076240842562887691Like on Twitter 13076240842562887691Twitter 1307624084256288769
SHTAC_uni_sotonSHTAC unisouthampton@SHTAC_uni_soton·
19 Sep

Fantastic opportunity to join the team at SHTAC, we are looking for two researchers to work on health technology assessments and other research https://jobs.soton.ac.uk/Vacancy.aspx?ref=1290920VB
#HTA #healtheconomics

Reply on Twitter 1307270208311062529Retweet on Twitter 1307270208311062529Like on Twitter 1307270208311062529Twitter 1307270208311062529
Theriaque_CNHIMTheriaque_officiel@Theriaque_CNHIM·
19 Sep

L' #HTA réfractaire associée à un plus grand risque cardiovasculaire et de décès que l'HTA résistante
JAHA
https://www.apmnews.com:443/story.php?objet=356324

Reply on Twitter 1307231302790320129Retweet on Twitter 1307231302790320129Like on Twitter 1307231302790320129Twitter 1307231302790320129
Load More...
Privacy Policy | Disclaimer
Copyright © 2020 ISPOR – The Professional Society for Health Economics and Outcomes Research